LIGAND PHARMACEUTICALS INCORPORATED Business Acquisition, Pro Forma Revenue
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Business Acquisition, Pro Forma Revenue of $17.29 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-14.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2012-11-14
- LIGAND PHARMACEUTICALS INCORPORATED business acquisition, pro forma revenue for the quarter ending 2012-09-30 was $5.74M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month |
|---|---|---|---|
| 2012-09-30 | $5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $17.29M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $11.55M 10-Q · filed 2012-08-08 |